2025. The 31-GEP Stratifies Risk of Death in Patients with Stage I-IIA Cutaneous Melanoma: A SEER Real-World Evidence Study. SKIN The Journal of Cutaneous Medicine. 9, 4 (Jul. 2025), s586. DOI:https://doi.org/10.25251/ys9mt689.